PharmaVigilant Launches New User Interface for I-Warehouse
PharmaVigilant announced the availability of I-Warehouse 3.0, an enhanced version of the company’s unprecedented clinical data warehouse. The state-of-the-art system gives companies an innovative technology solution that provides immediate and ubiquitous access to study data with comparable results.
With I-Warehouse 3.0, the user interface has been redesigned to address the increasingly complex clinical trial environment. New features and functionality now streamline reporting to accommodate even more complex queries across multiple trials, and provides clients with access to their data at their fingertips. I-Warehouse offers superior organization of search criteria and a more streamlined selection process with drag and drop features, pre-populated mathematical calculations, and one-click results in the form of data on demand. Additionally, descriptive graphical summaries render visual components for study data results and report comparisons.
Additional features of I-Warehouse 3.0 include:
- Data on demand
- Import utility enabling competitive datasets to be incorporated into I-Warehouse
- Excel and PDF exports
- Customized charts and graphs
- Report regeneration
- Saved search criteria
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
